The Centers for Disease Control and Prevention has updated its interim guidance for health care professionals for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection. The guidance includes criteria for who should be evaluated for MERS-CoV, which have been updated to include individuals with fever and pneumonia or acute respiratory distress syndrome who have a history of being in a health care facility as a patient, worker or visitor in South Korea within 14 days of symptom onset. The guidance also contains guidelines for the evaluation and management of close contacts, as well as reporting, laboratory testing and infection control. CDC said it will update the infection control guidance in the coming days. MERS-CoV, which can be fatal, was first reported in Saudi Arabia in 2012 and has since spread to several other countries, including South Korea, where an outbreak was first reported in May. For more, including common signs and symptoms, see the CDC’s MERS webpage

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Nov. 25 announced lower prices for 15 Medicare Part D drugs selected for the second cycle of negotiations…
Headline
The Assistant Secretary for Technology Policy/Office of the National Coordinator for Health IT announced Nov. 24 that it will exercise temporary enforcement…
Headline
The Centers for Medicare & Medicaid Services Nov. 25 issued a proposed rule for policies governing the Medicare Advantage and Part D programs for 2027. CMS…
Headline
The Trump administration issued an executive order Nov. 24 launching the Genesis Mission, an artificial intelligence initiative focusing on scientific research…
Headline
The Food and Drug Administration has identified a Class I recall of Max Mobility/Permobil SpeedControl Dials used with the SmartDrive MX2+ Power Assist Device…
Headline
A Washington resident recently hospitalized with the H5N5 strain of bird flu died Nov. 21, according to the Washington State Department of Health. The…